MCMarcella Cipelli

Marcella Cipelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcella Cipelli has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HIF-1α Restrains Oxidative Metabolism and Suppressive Function in RORγt⁺ Regulatory T Cells

    by Marcella Cipelli, Eloisa Martins da Silva, Luísa Menezes-Silva, See Pdf

    Regulatory T cells (Tregs) expressing RORγt accumulate in the intestinal mucosa, but the signals that determine whether these cells remain suppressive or acquire inflammatory features are incompletely defined. Here, we identified Crohn’s disease (CD)-enriched FOXP3⁺ T-cell states in human ileal single-cell data that converged on RORC, HIF1A, hypoxia-responsive, inflammatory, and metabolic programs. Genetic deletion of HIF1A (ΔHIF1A) in RORγt-expressing cells protected mice from acute DSS colitis, T-cell transfer colitis, and azoxymethane/DSS-induced colitis-associated colorectal cancer (CAC). In Rag1-/- recipients given the same pathogenic naïve T cells, cotransfer of ΔHIF1A Tregs provided greater protection than cotransfer of WT Tregs, directly linking the phenotype to regulatory-cell function in vivo. Reanalysis of mouse colonic Treg scATAC-seq showed that RORγt⁺ Tregs with low HIF1A motif-associated accessibility preferentially engaged an oxidative, mitochondrial-fitness program characterized by greater Cpt1a, Opa1, and Mfn2 activity, whereas the motif-high state favored stress- and glycolysis-associated accessibility. Consistently, ΔHIF1A RORγt⁺ Tregs produced more IL-10 and less IL-17A and IFN-γ, more strongly limited responder-cell proliferation in vitro, contained fewer dysfunctional and mitochondrial-reactive-oxygen-species-high cells, favored fusion-associated transcription, and displayed greater basal and maximal oxygen consumption and reserve capacity, a profile lost after oxidative metabolism blockage with Oligomycin. In human CD, trajectory and gene-regulatory-network analyses further predicted that HIF1A perturbation would oppose selected disease-associated branches. Together, these data identify HIF-1α as a metabolic checkpoint connecting hypoxia-responsive transcription to mitochondrial fitness and inflammatory plasticity in intestinal RORγt⁺ Tregs.

  • Butyrate improves the metabolism of proximal tubular cells and attenuates tissue damage in oxalate-induced acute kidney injury

    by Orestes Foresto-Neto, Paulo José Basso, Thaís Alves-Silva, Luis Felipe Serra Moreira, Marcella Cipelli, Marcos Antônio Cenedeze, Ingrid Kazue Mizuno Watanabe, Magaiver Andrade-Silva, Letícia Felix Reis, Meire Ioshie Hiyane, et al.

    This study identifies the short-chain fatty acid butyrate as a protector against calcium oxalate-induced acute kidney injury. We demonstrate that butyrate enhances mitochondrial respiration and peroxisomal gene expression in proximal tubular cells, preserves renal function, and attenuates tubular injury through GPR109A-dependent mechanisms. These findings reveal a previously unrecognized link between butyrate signaling and renal protection, highlighting GPR109A as a potential therapeutic target in oxalate-induced kidney injury.

  • Open Access

    Activated macrophages restrict invasive bacterial infection in a human intestinal organoid co-culture model

    by Lisa F. Goertz, Marcella Cipelli, Manuela Buettner, Guntram A. Grassl, Matthias Lochner

    Intestinal organoids provide physiologically relevant models of the epithelial barrier, but lack the immune compartment that critically shapes host responses to infection. Here, we established a human colon organoid-derived monolayer co-culture system with macrophage-like THP-1 cells positioned directly beneath the epithelial layer. The model enabled controlled apical infection with Listeria monocytogenes and Salmonella Typhimurium while preserving epithelial barrier integrity. PMA-differentiated THP-1 cells reduced intracellular L. monocytogenes burden, whereas additional activation with IFN-γ and LPS resulted in a pronounced reduction of both L. monocytogenes and S. Typhimurium, accompanied by decreased infection-associated cytotoxicity. Bulk RNA sequencing revealed a distinct co-culture transcriptional signature characterized by coordinated changes in inflammatory, antimicrobial, and epithelial lineage-associated programs. These included reduced HLA-D/MHC class II-associated gene expression, altered S100A8/S100A9 expression, and changes in epithelial lineage markers indicating a shift in epithelial cellular composition and differentiation state. Together, these findings establish a versatile human organoid-macrophage platform for dissecting epithelial-immune interactions and macrophage-associated control of invasive bacterial infection.

  • Open Access

    Kidney Health in a Changing Climate

    by Suemy Melim Yamada, Marcella Cipelli, Pablo Shimaoka Chagas, Pedro Imenez Silva, Niels Olsen Saraiva Câmara

    Climate change has reshaped global health in unprecedented ways, with CKD increasingly recognized as a major climate-sensitive condition. Kidney diseases affect an estimated 850 million people worldwide, and countries with the highest incidence are often facing rapid social and economic vulnerability alongside sustained rises in annual temperatures. A growing body of evidence has demonstrated that recurrent heat exposure, failures in heat dissipation, and associated environmental stressors markedly increase the risk of acute kidney injury and accelerate its progression to CKD. On the other hand, epidemiological indicators reinforce this relationship, showing approximately a 30% increase in kidney disease morbidity in regions exposed to high heat, as well as heat-associated CKD epidemics in Central America, Mexico, India, and Sri Lanka, even in the absence of traditional risk factors. These patterns suggested that chronic heat stress and repeated dehydration during manual labor may act as catalysts that unmask metabolic vulnerabilities or enhance susceptibility to nephrotoxic exposures. In this review, we integrated robust population-level data with mechanistic biological insights to explain how these climatic trends disproportionately affect vulnerable populations. We examined historical and contemporary temperature trajectories, identified countries with the greatest climatic and epidemiological burden, and presented key indicators such as incidence, mortality, and clinically relevant population metrics. At the molecular level, we connected these findings to heat-sensitive pathways involving dehydration, mitochondrial dysfunction, tubular injury, inflammation, renal hypoperfusion, and uric acid stone formation. Finally, we situated these processes within the ecological and evolutionary context of human thermoregulation, highlighting a growing adaptation lag between accelerating global warming and the limits of human physiological resilience. Thus, we argued that a comprehensive understanding of these multilevel interactions, from environmental conditions to cellular metabolism, is crucial for shaping effective prevention efforts, early diagnostic strategies, and evidence-based policies capable of mitigating the global rise of heat-associated kidney disease.


  • Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia

    by Keli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, Maria Fernanda Lopes Carvalho, Diego Antonio Pereira-Martins, Wellington Fernandes da Silva, Rita de Cássia Cavaglieri, Luciana Nardinelli, Aline de Medeiros Leal, Elvira Deolinda Rodrigues Pereira Velloso, et al.


  • Open Access

    The impact of hypoxia-inducible factors in the pathogenesis of kidney diseases: a link through cell metabolism

    by Orestes Foresto-Neto, Ana Ruth Paolinetti Alves da Silva, Marcella Cipelli, Fernanda Paula Roncon Santana-Novelli, Niels Olsen Saraiva Camara

    Kidneys are sensitive to disturbances in oxygen homeostasis. Hypoxia and activation of the hypoxia-inducible factor (HIF) pathway alter the expression of genes involved in the metabolism of renal and immune cells, interfering with their functioning. Whether the transcriptional activity of HIF protects the kidneys or participates in the pathogenesis of renal diseases is unclear. Several studies have indicated that HIF signaling promotes fibrosis in experimental models of kidney disease. Other reports showed a protective effect of HIF activation on kidney inflammation and injury. In addition to the direct effect of HIF on the kidneys, experimental evidence indicates that HIF-mediated metabolic shift activates inflammatory cells, supporting the HIF cascade as a link between lung or gut damage and worsening of renal disease. Although hypoxia and HIF activation are present in several scenarios of renal diseases, further investigations are needed to clarify whether interfering with the HIF pathway is beneficial in different pathological contexts.


  • Open Access

    MS‐Driven Metabolic Alterations Are Recapitulated in iPSC‐Derived Astrocytes

    by Bruno Ghirotto, Danyllo F. Oliveira, Marcella Cipelli, Paulo J. Basso, Jean de Lima, Cristiane N. S. Breda, Henrique C. Ribeiro, Camille C. C. Silva, Andrea L. Sertié, Antonio Edson R. Oliveira, et al.

    Objective: Astrocytes play a significant role in the pathology of multiple sclerosis (MS). Nevertheless, for ethical reasons, most studies in these cells were performed using the Experimental Autoimmune Encephalomyelitis model. As there are significant differences between human and mouse cells, we aimed here to better characterize astrocytes from patients with MS (PwMS), focusing mainly on mitochondrial function and cell metabolism.Methods: We obtained and characterized induced pluripotent stem cell (iPSC)‐derived astrocytes from three PwMS and three unaffected controls, and performed electron microscopy, flow cytometry, cytokine and glutamate measurements, gene expression, in situ respiration, and metabolomics. We validated our findings using a single‐nuclei RNA sequencing dataset.Results: We detected several differences in MS astrocytes including: (i) enrichment of genes associated with neurodegeneration, (ii) increased mitochondrial fission, (iii) increased production of superoxide and MS‐related proinflammatory chemokines, (iv) impaired uptake and enhanced release of glutamate, (v) increased electron transport capacity and proton leak, in line with the increased oxidative stress, and (vi) a distinct metabolic profile, with a deficiency in amino acid catabolism and increased sphingolipid metabolism, which have already been linked to MS.Interpretation: Here we describe the metabolic profile of iPSC‐derived astrocytes from PwMS and validate this model as a very powerful tool to study disease mechanisms and to perform non‐invasive drug targeting assays in vitro. Our findings recapitulate several disease features described in patients and provide new mechanistic insights into the metabolic rewiring of astrocytes in MS, which could be targeted in future therapeutic studies. ANN NEUROL 2022;91:652–669


  • Open Access

    MS-driven metabolic alterations are recapitulated in iPSC-derived astrocytes

    by Bruno Ghirotto, Danyllo F. Oliveira, Marcella Cipelli, Paulo J. Basso, Jean de Lima, Cristiane N. S. Breda, Henrique C. Ribeiro, Camille C. C. Silva, Meire I. Hiyane, Elia G. Caldini, et al.

    Objective: Astrocytes play a significant role in the pathology of Multiple Sclerosis (MS). Nevertheless, for ethical reasons, most of the studies in these cells were performed on the Experimental Autoimmune Encephalomyelitis model. As there are significant differences between human and mouse cells, we aimed here to better characterize astrocytes from patients with MS (PwMS), focusing mainly on mitochondrial function and cell metabolism. Methods: We obtained and characterized induced pluripotent stem cell (iPSC)-derived astrocytes from three PwMS and three unaffected controls and performed functional assays including electron microscopy, flow cytometry, cytokine measurement, gene expression, in situ respiration, and metabolomics. Results: We detected several differences in MS astrocytes including: (i) enrichment of genes associated with mitophagy and neurodegeneration, (ii) increased mitochondrial fission and decreased mitochondrial to nuclear DNA ratio, indicating disruption of mitochondrial content, (iii) increased production of superoxide and MS-related proinflammatory chemokines, (iv) increased electron transport capacity and proton leak, in line with the increased oxidative stress, and (v) a distinct metabolic profile, with a deficiency in amino acid catabolism and increased sphingolipid metabolism, which have already been linked to MS. Interpretation: To our knowledge, this is the first study thoroughly describing the metabolic profile of iPSC-derived astrocytes from PwMS, and validating this model as a powerful tool to study disease mechanisms and to perform non-invasive drug targeting assays in vitro . Our findings recapitulate several disease features described in patients and provide new mechanistic insights into the metabolic rewiring of astrocytes in MS, which could be targeted in future therapeutic studies.


  • Open Access

    Swainsonine, an alpha-mannosidase inhibitor, may worsen cervical cancer progression through the increase in myeloid derived suppressor cells population

    by Caio Raony Farina Silveira, Marcella Cipelli, Carolina Manzine, Silvia Helena Rabelo-Santos, Luiz Carlos Zeferino, Gretel Rodríguez Rodríguez, Josiane Betim de Assis, Suellen Hebster, Isabel Bernadinelli, Fabio Laginha, et al.

    Cervical cancer, caused by high oncogenic risk Human Papillomavirus (HPV) infection, continues to be a public health problem, mainly in developing countries. Using peptide phage display as a tool to identify potential molecular targets in HPV associated tumors, we identified α-mannosidase, among other enriched sequences. This enzyme is expressed in both tumor and inflammatory compartment of the tumor microenvironment. Several studies in experimental models have shown that its inhibition by swainsonine (SW) led to inhibition of tumor growth and metastasis directly and indirectly, through activation of macrophages and NK cells, promoting anti-tumor activity. Therefore, the aim of this work was to test if swainsonine treatment could modulate anti-tumor immune responses and therefore interfere in HPV associated tumor growth. Validation of our biopanning results showed that cervical tumors, both tumor cells and leukocytes, expressed α-mannosidase. Ex vivo experiments with tumor associated macrophages showed that SW could partially modulate macrophage phenotype, decreasing CCL2 secretion and impairing IL-10 and IL-6 upregulation, which prompted us to proceed to in vivo tests. However, in vivo, SW treatment increased tumor growth. Investigation of the mechanisms leading to this result showed that SW treatment significantly induced the accumulation of myeloid derived suppressor cells in the spleen of tumor bearing mice, which inhibited T cell activation. Our results suggested that SW contributes to cervical cancer progression by favoring proliferation and accumulation of myeloid cells in the spleen, thus exacerbating these tumors systemic effects on the immune system, therefore facilitating tumor growth.